Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J. D. Kobalava"'
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 6 (2020)
Aim. To analyze the efficacy and tolerability of amlodipine/indapamide/perindopril arginine (Triplixam) in a subgroup of 790 people participating in the Russian observational program DOKAZATEL`STVO without use of other antihypertensive agents.Materia
Externí odkaz:
https://doaj.org/article/40f2dc0413b74c5aaee5f66c84df3026
Autor:
Yu. V. Kotovskaya, J. D. Kobalava
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 38-44 (2015)
In spite of the fact that clinical measurement of blood pressure which meets methodical requirements is still a basis for diagnostics of arterial hypertension and assessment of treatment efficiency, it is widely recognized that proper diagnostics and
Externí odkaz:
https://doaj.org/article/64678f8a0be641deb90768329af83b86
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 2, Pp 220-230 (2015)
Review of scientific evidences on contemporary concepts of the pathogenesis of mechanical dyssynchrony and its significance in patients with chronic heart failure is presented.
Externí odkaz:
https://doaj.org/article/ae2e3976da654aea882e6246316bbd08
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 1, Pp 83-91 (2015)
Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD is characterized by accelerated aging of vessels in which the age-related arterial stiffness increase is exacerbated by a number of uremia-related processes. Increased
Externí odkaz:
https://doaj.org/article/e060b1fb356c4fbbbed7a2eb19329896
Autor:
V. C. Moiseev, N. A. Mukhin, A. V. Smirnov, J. D. Kobalava, I. N. Bobkova, S. V. Villevalde, M. A. Yefremovtseva, L. V. Kozlovskaya, M. Yu. Shvetsov, M. V. Shestakova, G. P. Arutyunov, S. A. Boytsov, A. S. Galyavich, Y. I. Greenstein, V. A. Dobronravov, O. M. Drapkina, V. M. Ermolenko, Yu. A. Karpov, I. G. Kayukov, J. V. Kotovsky, V. V. Kukharchuk, A. I. Martynov, T. E. Morozova, R. G. Oganov, V. I. Podzolkov, L. Ya. Rozhinskaya, S. N. Tereshchenko, V. V. Fomin, V. N. Khirmanov, I. E. Chazova, M. Sh. Shamkhalova, E. M. Shilov, E. V. Shlyakhto, A. M. Shutov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 7-37 (2014)
Externí odkaz:
https://doaj.org/article/d1bd210a3de646beb2e4bd0da7c2ac53
Autor:
J. D. Kobalava, Yu. V. Kotovskaya
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 77-84 (2014)
The ageing is the main risk factor for arterial hypertension (AH) and cardiovascular diseases. Natural ageing with normal BP is followed by changes in large arteries (rigidity), myocardium (hypertrophy) and diastolic relaxation and filling of cardiac
Externí odkaz:
https://doaj.org/article/5f66876f71b4488cb4fc5f297b34b570
Autor:
A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 4, Pp 75-78 (2013)
Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.
Externí odkaz:
https://doaj.org/article/16dc7004b2a04aecb190a64ca269eadf
Autor:
I I Shaposhnik, V. V. Kashtalap, A. V. Susekov, V Yu Mareev, J. D. Kobalava, A. M. Galyavich, A. I. Kaminnyi, Victor S. Gurevich
Publikováno v:
Kardiologiia. 59(5S)
This Conclusion of the Board of experts is devoted to the analysis of the evidence base, the position in modern clinical guidelines, the efficacy and safety analysis as well as the options of combined therapy with statins and ezetimibe (Otrio, JSC
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 10, Iss 2, Pp 220-230 (2015)
Review of scientific evidences on contemporary concepts of the pathogenesis of mechanical dyssynchrony and its significance in patients with chronic heart failure is presented.
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 10, Iss 1, Pp 83-91 (2015)
Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD is characterized by accelerated aging of vessels in which the age-related arterial stiffness increase is exacerbated by a number of uremia-related processes. Increased